| A randomized trial of efficacy of beta-sitosterol and its glucoside as adjuvant to cryotherapy in the treatment of anogenital warts 2015 · Cryotherapy and BSS-BSSG mixture · Patients with anogenital warts; age and sex not specified | 200 mcg | — | 63 |
| The effect of a low-fat spread with added plant sterols on vascular function markers: results of the Investigating Vascular Function Effects of Plant Sterols (INVEST) study 2015 · PS group · Men and postmenopausal women aged 40–65 with borderline-high to high LDL cholesterol (130–190 mg/dL or 3.4–4.9 mmol/L), otherwise apparently healthy | 3 g | 12 weeks | 126 |
| Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels 2006 · plant stanol yogurt · Children aged 7–12 years with familial hypercholesterolemia | 2 g | 4 weeks | 42 |
| Short-term effects and safety of a natural oral supplement containing glucosinolates, phytosterols, and citrus flavonoids compared with hormone treatment for the management of postmenopausal symptomatic women: a pilot single-center randomized phase 2 clinical trial 2023 · G2 · Postmenopausal women with menopausal symptoms | 3 g | 90 days | 20 |
| Pigmented rice bran and plant sterol combination reduces serum lipids in overweight and obese adults 2014 · RB + PS group · Healthy men and women aged 21–50 who were overweight or obese (BMI 29–35 kg/m²) | 1.8 g | 8 weeks | — |
| Randomized controlled trial of the effect of phytosterols-enriched low-fat milk on lipid profile in Chinese 2017 · treatment group · Healthy Southern Chinese adults aged 18 years or older, male or female | 1.5 g | 3 weeks | 110 |
| Long-term Effects of Plant Stanols on the Lipid Profile of Patients With Hypercholesterolemia. A Randomized Clinical Trial 2015 · intervention group · Adults with hypercholesterolemia; age range and sex not specified | 2 g | 1 year | 91 |
| Effect of a novel functional tomato sauce (OsteoCol) from vine-ripened tomatoes on serum lipids in individuals with common hypercholesterolemia: tomato sauce and hypercholesterolemia 2021 · Sterol-enriched yogurt · Adults aged 20–75 with newly diagnosed polygenic hypercholesterolemia | 1.6 g | 6 weeks | 91 |
| The lipid-lowering effect of once-daily soya drink fortified with phytosterols in normocholesterolaemic Chinese: a double-blind randomized controlled trial 2020 · phytosterols-enriched soya drink · Chinese adults aged 19–79 years with normocholesterolaemia; men and women | 2 g | 3 weeks | 82 |
| Effects of phytosterol ester-enriched margarine on plasma lipoproteins in mild to moderate hypercholesterolemia are related to basal cholesterol and fat intake 2002 · phytosterol ester-enriched margarine · Healthy adults, 42 ± 11 years, with mild to moderate hypercholesterolemia (LDL cholesterol >130 mg/dL) | 1.82 g | 3 weeks | 63 |
| Lathosterol-to-cholesterol ratio in serum predicts cholesterol-lowering response to plant sterol consumption in a dual-center, randomized, single-blind placebo-controlled trial 2015 · plant sterol (PS) · mildly hypercholesterolemic adults preselected for high or low endogenous cholesterol synthesis | 2 g | 4 weeks | 63 |
| CYP7A1-rs3808607 and APOE isoform associate with LDL cholesterol lowering after plant sterol consumption in a randomized clinical trial 2015 · plant sterols (PSs) · Mildly hypercholesterolemic adults preselected for high or low endogenous cholesterol synthesis | 2 g | 4 weeks | 63 |
| The effects of plant stanol ester consumption on arterial stiffness and endothelial function in adults: a randomised controlled clinical trial 2013 · staest group · Adults aged 25–66 years, men and women, without a stated cardiovascular disease; varying serum lipid levels | 3 g | 26 weeks | 46 |
| Genosets for APOE and CYP7A1-rs3808607 variants do not predict LDL cholesterol lowering upon intervention with plant sterols in a randomized, double-blind, placebo-controlled trial 2022 · plant sterol intervention · Adults with slightly elevated LDL cholesterol, recruited based on prespecified APOE and CYP7A1 genosets; age and sex range not reported | 2 g | 4 weeks | 42 |
| Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia 2003 · plant sterol spread · Children aged 5–12 years with familial hypercholesterolaemia | 2.3 g | 4 weeks | 41 |
| Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters 2000 · 2.5 g plant stanols at lunch · Healthy normocholesterolemic or mildly hypercholesterolemic subjects; age and sex not specified | 2.5 g | 4 weeks | 39 |
| Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters 2000 · 2.5 g plant stanols divided over the three meals · Healthy normocholesterolemic or mildly hypercholesterolemic subjects; age and sex not specified | 2.5 g | 4 weeks | 39 |
| Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia 2002 · placebo plus sterol-ester margarine · Men and women with primary hypercholesterolemia and baseline LDL cholesterol at least 97 mg/dL | 2 g | 4 weeks | 39 |
| Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia 2002 · SE-enriched spread period · Children aged 7–12 years with familial hypercholesterolemia | 1.6 g | 8 weeks | 38 |
| Plasma lathosterol measures rates of cholesterol synthesis and efficiency of dietary phytosterols in reducing the plasma cholesterol concentration 2022 · PS group · Adults aged 38–77 with hypercholesterolemia (total cholesterol 200–300 mg/dL and LDL-C ≥130 mg/dL) | 1.6 g | 4 weeks | 38 |
| Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia 2002 · cerivastatin plus sterol-ester margarine · Men and women with primary hypercholesterolemia and baseline LDL cholesterol at least 97 mg/dL | 2 g | 4 weeks | 37 |
| Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread 2004 · Children consuming PSE spread · Children aged 7–13 years diagnosed with definite or possible heterozygous familial hypercholesterolemia | 1.2 g | 26 weeks | 37 |
| Vegetable oil based versus wood based stanol ester mixtures: effects on serum lipids and hemostatic factors in non-hypercholesterolemic subjects 2000 · vegetable oil based stanol ester mixture · Non-hypercholesterolemic men and women | 3.8 g | 8 weeks | 36 |
| Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesteryl ester transfer protein, and oxidized low-density lipoprotein by plant stanol ester-containing spread: a randomized, placebo-controlled trial 2003 · 3 g/d plant stanol group · Healthy Japanese volunteers | 3 g | 4 weeks | 36 |
| The cholesterol lowering efficacy of plant stanol ester yoghurt in a Turkish population: a double-blind, placebo-controlled trial 2013 · Plant stanol yoghurt group · Adults aged 20–70 with untreated mild to moderate hypercholesterolemia | 1.9 g | 4 weeks | 35 |
| Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesteryl ester transfer protein, and oxidized low-density lipoprotein by plant stanol ester-containing spread: a randomized, placebo-controlled trial 2003 · 2 g/d plant stanol group · Healthy Japanese volunteers | 2 g | 4 weeks | 34 |
| Low and moderate-fat plant sterol fortified soymilk in modulation of plasma lipids and cholesterol kinetics in subjects with normal to high cholesterol concentrations: report on two randomized crossover studies 2009 · Low-fat PS-enriched soymilk · Adults aged 19–60, men and women, with LDL-C 2.1–5.2 mmol/L and triglycerides below 2.82 mmol/L; normal to high cholesterol concentrations | 1.95 g | 4 weeks | 33 |
| Lipid-altering effects of a dietary supplement tablet containing free plant sterols and stanols in men and women with primary hypercholesterolaemia: a randomized, placebo-controlled crossover trial 2012 · Active non-esterified sterol/stanol tablets · Men and women aged 21–79 years with primary hypercholesterolaemia | 1.8 g | 6 weeks | 32 |
| A Randomized, Placebo-Controlled, Double-Blind Crossover Study to Assess a Unique Phytosterol Ester Formulation in Lowering LDL Cholesterol Utilizing a Novel Virtual Tracking Tool 2019 · phytosterol intervention · Adults aged 30–65 with elevated LDL cholesterol and low HDL cholesterol; non-smokers | 1.5 g | 30 days | 32 |
| Effects of phytosterol ester-enriched low-fat milk on serum lipoprotein profile in mildly hypercholesterolaemic patients are not related to dietary cholesterol or saturated fat intake 2010 · healthy diet+PS · mildly hypercholesterolaemic patients; age and sex not specified | 2 g | 90 days | 31 |
| Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble antioxidant concentrations 2002 · experimental yoghurt group · Non-hypercholesterolemic subjects; age and sex not specified | 3 g | 4 weeks | 30 |
| Cocoa, hazelnuts, sterols and soluble fiber cream reduces lipids and inflammation biomarkers in hypertensive patients: a randomized controlled trial 2012 · Product C (cocoa+hazelnuts+phytosterols cream) · Men and women older than 20 with prehypertension or stage-1 hypertension, LDL cholesterol 3.35–4.88 mmol/L, and at least one cardiovascular risk factor | 2 g | 4 weeks | 30 |
| A softgel dietary supplement containing esterified plant sterols and stanols improves the blood lipid profile of adults with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled replication study 2014 · sterol/stanol treatment condition · Adults with primary hypercholesterolemia; 8 men and 22 women were randomized, but the age range is not reported. | 1.8 g | — | 30 |
| [Low fat milk powder containing esterified plant sterols improves the blood lipid profile of adults with hypercholesterolemia] 2014 · treatment group · Adults with primary hypercholesterolemia; mean age 60.28 years; sex composition not fully specified | 2.5 g | 6 weeks | 30 |
| Plant sterols are efficacious in lowering plasma LDL and non-HDL cholesterol in hypercholesterolemic type 2 diabetic and nondiabetic persons 2005 · plant sterol diet · Adults with hypercholesterolemia: 15 nondiabetic participants and 14 participants with type 2 diabetes | 1.8 g | 3 weeks | 29 |
| Effects of phytosterol ester-enriched low-fat milk on serum lipoprotein profile in mildly hypercholesterolaemic patients are not related to dietary cholesterol or saturated fat intake 2010 · free diet+PS · mildly hypercholesterolaemic patients; age and sex not specified | 2 g | 90 days | 29 |
| Bakery products enriched with phytosterol esters, alpha-tocopherol and beta-carotene decrease plasma LDL-cholesterol and maintain plasma beta-carotene concentrations in normocholesterolemic men and women 2003 · sterol ester (SE) group · Normocholesterolemic adult men and women who habitually consumed bakery products; age range not reported | 3.2 g | 8 weeks | 28 |
| Lipid effects of a dietary supplement softgel capsule containing plant sterols/stanols in primary hypercholesterolemia 2013 · plant sterol/stanol softgel capsules · Adults with primary hypercholesterolemia, mean age 58.4 years; approximately 75% women | 1.8 g | 6 weeks | 28 |
| Cholesterol lowering effect of a soy drink enriched with plant sterols in a French population with moderate hypercholesterolemia 2008 · Soy drink enriched with plant sterols · Adults aged 19–65 with untreated moderate hypercholesterolemia | 2.6 g | 8 weeks | 25 |
| The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitamins 2010 · intervention group · People with mild to moderate hypercholesterolemia | 8.8 g | 10 weeks | 25 |
| Very high plant stanol intake and serum plant stanols and non-cholesterol sterols 2010 · plant stanol ester group (staest) · Hypercholesterolemic subjects, mean age 62 years (range 41–73); sex not specified | 8.8 g | 10 weeks | 25 |
| Serum lipids, plant sterols, and cholesterol kinetic responses to plant sterol supplementation in phytosterolemia heterozygotes and control individuals 2012 · plant sterol supplementation · Adults with phytosterolemia heterozygosity (ABCG8 S107X mutation) and healthy controls; mean age 34 years | 1.6 g | 4 weeks | 25 |
| Cholesterol reduction by different plant stanol mixtures and with variable fat intake 1999 · Sitostanol ester-rich rapeseed oil margarine · Postmenopausal women | 3.18 g | 6 weeks | 23 |
| Cholesterol reduction by different plant stanol mixtures and with variable fat intake 1999 · Campestanol ester-rich rapeseed oil margarine · Postmenopausal women | 3.16 g | 6 weeks | 23 |
| Cholesterol reduction by different plant stanol mixtures and with variable fat intake 1999 · Sitostanol ester-rich butter · Postmenopausal women | 2.43 g | 5 weeks | 23 |
| Low and moderate-fat plant sterol fortified soymilk in modulation of plasma lipids and cholesterol kinetics in subjects with normal to high cholesterol concentrations: report on two randomized crossover studies 2009 · Moderate-fat PS-enriched soymilk · Adults aged 19–60, men and women, with LDL-C above 3.4 mmol/L and triglycerides below 2.82 mmol/L | 1.95 g | 4 weeks | 23 |
| Effects of phytosterol supplementation on lipoprotein subfractions and LDL particle quality 2024 · diet plus phytosterol · Adults older than 18 years, both sexes, with dyslipidemia and LDL cholesterol 130 to below 190 mg/dL, in primary prevention at low or intermediate cardiovascular risk, without lipid-lowering drug therapy; completed sample was all male, age 42 ± 6 years | 2.6 g | 12 weeks | 23 |
| Phytosterol intake and dietary fat reduction are independent and additive in their ability to reduce plasma LDL cholesterol 2009 · 3.3 g/day plant sterols (PS), on either background diet · Mildly hypercholesterolemic men and postmenopausal women | 3.3 g | 23 days | 22 |
| Olive oil containing olive oil fatty acid esters of plant sterols and dietary diacylglycerol reduces low-density lipoprotein cholesterol and decreases the tendency for peroxidation in hypercholesterolaemic subjects 2007 · PS-SO treatment diet · Moderately overweight, hypercholesterolaemic subjects | 1.7 g | 4 weeks | 21 |
| Olive oil containing olive oil fatty acid esters of plant sterols and dietary diacylglycerol reduces low-density lipoprotein cholesterol and decreases the tendency for peroxidation in hypercholesterolaemic subjects 2007 · PS-OO treatment diet · Moderately overweight, hypercholesterolaemic subjects | 1.7 g | 4 weeks | 21 |
| Fish-oil esters of plant sterols differ from vegetable-oil sterol esters in triglycerides lowering, carotenoid bioavailability and impact on plasminogen activator inhibitor-1 (PAI-1) concentrations in hypercholesterolemic subjects 2007 · PS-SO · Men and postmenopausal women aged 30–65 years with mildly overweight hypercholesterolemia | 1.7 g | 4 weeks | 21 |
| Fish-oil esters of plant sterols differ from vegetable-oil sterol esters in triglycerides lowering, carotenoid bioavailability and impact on plasminogen activator inhibitor-1 (PAI-1) concentrations in hypercholesterolemic subjects 2007 · PS-OO · Men and postmenopausal women aged 30–65 years with mildly overweight hypercholesterolemia | 1.7 g | 4 weeks | 21 |
| Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread 2004 · Parents consuming PSE spread · Parents aged 32–51 years diagnosed with definite or possible heterozygous familial hypercholesterolemia | 1.5 g | 26 weeks | 20 |
| Plant sterol consumption frequency affects plasma lipid levels and cholesterol kinetics in humans 2009 · single-BF · 19 human subjects; age, sex, and health condition not specified | 1.8 g | 6 days | 19 |
| Plant sterol consumption frequency affects plasma lipid levels and cholesterol kinetics in humans 2009 · three times per day · 19 human subjects; age, sex, and health condition not specified | 1.8 g | 6 days | 19 |
| Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment 2008 · plant sterol ester-enriched margarine · Patients on stable statin treatment | 2.5 g | 85 weeks | 18 |
| Stearate-enriched plant sterol esters lower serum LDL cholesterol concentration in normo- and hypercholesterolemic adults 2009 · PS ester group · Normo- and hypercholesterolemic adults | 3 g | 4 weeks | 16 |
| Unesterified plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons 2002 · Plant sterols (NS) · Otherwise healthy hypercholesterolemic subjects | 1.8 g | — | 15 |
| Unesterified plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons 2002 · Plant stanols (SS) · Otherwise healthy hypercholesterolemic subjects | 1.8 g | — | 15 |
| Unesterified plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons 2002 · 50:50 mixture of sterols and stanols (NSS) · Otherwise healthy hypercholesterolemic subjects | 1.8 g | — | 15 |
| Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatment 2008 · plant sterol-enriched margarine · Patients receiving stable statin treatment | 2.5 g | 16 weeks | 15 |
| Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatment 2008 · stanol-enriched margarine · Patients receiving stable statin treatment | 2.5 g | 16 weeks | 15 |
| Effects of pravastatin, phytosterols, and combination therapy on lipid profile in HIV-infected patients: an open-labelled, randomized cross-over study 2015 · Combination therapy (phytosterols with pravastatin) · Adults aged 20 years or older with HIV infection, LDL-c at least 130 mg/dL on two occasions, and an unchanged antiretroviral regimen; combination first-phase group included 15 participants | 2 g | 4 weeks | 15 |
| Plant sterol/stanol prescription is an effective treatment strategy for managing hypercholesterolemia in outpatient clinical practice 2005 · intervention group · Adults referred to a dietary outpatient clinic for management of hyperlipidemia; ages and sex distribution for this arm not reported | 2 g | 12 weeks | 14 |
| Consumption of plant sterols-enriched soy milk with a healthy dietary pattern diet lowers blood pressure in adults with metabolic syndrome: A randomized controlled trial 2025 · PS group · Singaporean adults with metabolic syndrome | 2 g | 4 weeks | 13 |
| Plant stanol esters lower LDL cholesterol level in statin-treated subjects with type 1 diabetes by interfering the absorption and synthesis of cholesterol 2011 · STAEST group · Patients with type 1 diabetes receiving statin treatment; age and sex not reported | 3 g | 4 weeks | 12 |
| Effects of pravastatin, phytosterols, and combination therapy on lipid profile in HIV-infected patients: an open-labelled, randomized cross-over study 2015 · Phytosterols · Adults aged 20 years or older with HIV infection, LDL-c at least 130 mg/dL on two occasions, and an unchanged antiretroviral regimen; 50% male in this arm | 2 g | 4 weeks | 8 |
| Serum levels, absorption efficiency, faecal elimination and synthesis of cholesterol during increasing doses of dietary sitostanol esters in hypercholesterolaemic subjects 1994 · small-dose sitostanol ester · Mildly hypercholesterolaemic subjects; age and sex not specified | 800 mg | 9 weeks | 7 |
| Serum levels, absorption efficiency, faecal elimination and synthesis of cholesterol during increasing doses of dietary sitostanol esters in hypercholesterolaemic subjects 1994 · higher-dose sitostanol ester · Mildly hypercholesterolaemic subjects; age and sex not specified | 2 g | 6 weeks | 7 |
| Cholesterol-lowering effect of spreads enriched with microcrystalline plant sterols in hypercholesterolemic subjects 2001 · 1.5 g/d plant sterol spread group · Hypercholesterolemic subjects; age and sex not specified | 1.5 g | 26 weeks | — |
| Cholesterol-lowering effect of spreads enriched with microcrystalline plant sterols in hypercholesterolemic subjects 2001 · 3.0 g/d plant sterol spread group · Hypercholesterolemic subjects; age and sex not specified | 3 g | 26 weeks | — |
| Plant sterol-enriched margarine lowers plasma LDL in hyperlipidemic subjects with low cholesterol intake: effect of fibrate treatment 2001 · Plant sterol-enriched spread · Adults with primary hypercholesterolemia, 46–70 years; some participants were receiving fibrate treatment | 1.6 g | 60 days | — |
| Cholesterol-lowering effects of plant sterol esters and non-esterified stanols in margarine, butter and low-fat foods 2001 · Sterol ester-containing foods (Study 1) · Hypercholesterolaemic subjects; age and sex not reported | 2.4 g | 4 weeks | — |
| Cholesterol-lowering effects of plant sterol esters and non-esterified stanols in margarine, butter and low-fat foods 2001 · Non-esterified stanol-containing foods (Study 1) · Hypercholesterolaemic subjects; age and sex not reported | 2.4 g | 4 weeks | — |
| Cholesterol-lowering effects of plant sterol esters and non-esterified stanols in margarine, butter and low-fat foods 2001 · Sitosterol ester-fortified dairy fat spread (Study 2) · Hypercholesterolaemic subjects; age and sex not reported | 2.4 g | — | — |
| Plant sterol esters lower plasma lipids and most carotenoids in mildly hypercholesterolemic adults 2002 · Ranch dressing with plant sterol esters · Mildly hypercholesterolemic adult men and women | 3.6 g | 3 weeks | — |
| Plant sterol esters lower plasma lipids and most carotenoids in mildly hypercholesterolemic adults 2002 · Italian dressing with plant sterol esters · Mildly hypercholesterolemic adult men and women | 3.6 g | 3 weeks | — |
| Influence of apolipoprotein E phenotype on metabolism of lipids and apolipoproteins after plant stanol ester ingestion in Japanese subjects 2002 · 2 g/day plant stanol ester spread · Healthy Japanese volunteers; age and sex not specified | 2 g | 4 weeks | — |
| Influence of apolipoprotein E phenotype on metabolism of lipids and apolipoproteins after plant stanol ester ingestion in Japanese subjects 2002 · 3 g/day plant stanol ester spread · Healthy Japanese volunteers; age and sex not specified | 3 g | 4 weeks | — |
| Safety of long-term consumption of plant sterol esters-enriched spread 2003 · Plant sterol ester-enriched spread · Healthy adults aged 35–64 years | 1.6 g | 1 year | — |
| Plant sterol-fortified orange juice effectively lowers cholesterol levels in mildly hypercholesterolemic healthy individuals 2004 · sterol OJ · Mildly hypercholesterolemic healthy subjects; age range and sex not specified | 2 g | 8 weeks | — |
| Cholesterol-lowering effects of plant sterol esters differ in milk, yoghurt, bread and cereal 2004 · bread · Free-living men and women, mean age 54 years, with moderately elevated plasma total cholesterol | 1.6 g | 3 weeks | — |
| Cholesterol-lowering effects of plant sterol esters differ in milk, yoghurt, bread and cereal 2004 · breakfast cereal · Free-living men and women, mean age 54 years, with moderately elevated plasma total cholesterol | 1.6 g | 3 weeks | — |
| Effect of free plant sterols in low-fat milk on serum lipid profile in hypercholesterolemic subjects 2004 · Lo · Mildly hypercholesterolemic patients; age and sex not stated | 1.2 g | 4 weeks | — |
| Effect of free plant sterols in low-fat milk on serum lipid profile in hypercholesterolemic subjects 2004 · Hi · Mildly hypercholesterolemic patients; age and sex not stated | 1.6 g | 4 weeks | — |
| Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels 2005 · 10 mg/day ezetimibe combined with 25 g/day spread containing 2.0 g of plant sterols · Adults with mild hypercholesterolemia | 2 g | 4 weeks | — |
| Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels 2005 · 25 g/day spread containing 2.0 g of plant sterols · Adults with mild hypercholesterolemia | 2 g | 4 weeks | — |
| Intake occasion affects the serum cholesterol lowering of a plant sterol-enriched single-dose yoghurt drink in mildly hypercholesterolaemic subjects 2006 · Drink A with a meal · Adults of both sexes with mild hypercholesterolaemia; mean age 57 years | 3 g | 4 weeks | — |
| Intake occasion affects the serum cholesterol lowering of a plant sterol-enriched single-dose yoghurt drink in mildly hypercholesterolaemic subjects 2006 · Drink A without a meal · Adults of both sexes with mild hypercholesterolaemia; mean age 57 years | 3 g | 4 weeks | — |
| Intake occasion affects the serum cholesterol lowering of a plant sterol-enriched single-dose yoghurt drink in mildly hypercholesterolaemic subjects 2006 · Drink B with a meal · Adults of both sexes with mild hypercholesterolaemia; mean age 57 years | 3 g | 4 weeks | — |
| Intake occasion affects the serum cholesterol lowering of a plant sterol-enriched single-dose yoghurt drink in mildly hypercholesterolaemic subjects 2006 · Drink B without a meal · Adults of both sexes with mild hypercholesterolaemia; mean age 57 years | 3 g | 4 weeks | — |
| Effects of low-fat hard cheese enriched with plant stanol esters on serum lipids and apolipoprotein B in mildly hypercholesterolaemic subjects 2006 · plant stanol ester group · Mildly hypercholesterolaemic adults; 24 men and 43 women participated in the study overall | 2 g | 5 weeks | — |
| Basal plasma concentrations of plant sterols can predict LDL-C response to sitosterol in patients with familial hypercholesterolemia 2008 · Low-cholesterol plus plant sterol diet · Adults with familial hypercholesterolemia | 2 g | 4 weeks | — |
| Dose-response effects of different plant sterol sources in fat spreads on serum lipids and C-reactive protein and on the kinetic behavior of serum plant sterols 2008 · plant sterols, 1.6 g/day phase · Free-living adults from the general community with elevated cholesterol concentrations | 1.6 g | 3 weeks | — |
| Dose-response effects of different plant sterol sources in fat spreads on serum lipids and C-reactive protein and on the kinetic behavior of serum plant sterols 2008 · plant sterols, 3.0 g/day phase · Free-living adults from the general community with elevated cholesterol concentrations | 3 g | 3 weeks | — |
| Phytosterols dissolved in diacylglycerol oil reinforce the cholesterol-lowering effect of low-dose pravastatin treatment 2008 · PS/DAG oil group · Hypercholesterolemic outpatients receiving low-dose pravastatin | 502 mg | — | — |
| [Minimal effective dose on serum cholesterol concentration and the safety evaluation of dressing containing plant sterol in Japanese subjects] 2008 · 400 mg/day plant sterol group (Experiment 1) · Healthy Japanese men with total cholesterol ≥170 mg/dL | 400 mg | 4 weeks | — |
| [Minimal effective dose on serum cholesterol concentration and the safety evaluation of dressing containing plant sterol in Japanese subjects] 2008 · 800 mg/day plant sterol group (Experiment 1) · Healthy Japanese men with total cholesterol ≥170 mg/dL | 800 mg | 4 weeks | — |
| [Minimal effective dose on serum cholesterol concentration and the safety evaluation of dressing containing plant sterol in Japanese subjects] 2008 · 1200 mg/day plant sterol group (Experiment 1) · Healthy Japanese men with total cholesterol ≥170 mg/dL | 1.2 g | 4 weeks | — |
| Plant sterol-enriched fermented milk enhances the attainment of LDL-cholesterol goal in hypercholesterolemic subjects 2008 · phytosterol-enriched fermented milk · hypercholesterolemic patients who were not at therapeutic goals; age and sex not reported | 1.6 g | 6 weeks | — |
| Efficacy of plant sterols is not influenced by dietary cholesterol intake in hypercholesterolemic individuals 2008 · Low-cholesterol diet with plant sterols (C(-)S(+)) · Otherwise healthy hypercholesterolemic adults; age and sex not reported | 22 mg/kg | 4 weeks | — |
| Efficacy of plant sterols is not influenced by dietary cholesterol intake in hypercholesterolemic individuals 2008 · High-cholesterol diet with plant sterols (C(+)S(+)) · Otherwise healthy hypercholesterolemic adults; age and sex not reported | 22 mg/kg | 4 weeks | — |
| Plant stanol ester consumption and arterial elasticity and endothelial function 2008 · Camelina oil spread with stanol ester · Adults with serum cholesterol >5 mmol/l | 2 g | 90 days | — |
| Plant stanol ester consumption and arterial elasticity and endothelial function 2008 · Rapeseed oil spread with stanol ester · Adults with serum cholesterol >5 mmol/l | 2 g | 90 days | — |
| Plant stanol ester consumption and arterial elasticity and endothelial function 2008 · Sunflower oil spread with stanol ester · Adults with serum cholesterol >5 mmol/l | 2 g | 90 days | — |
| Independent and interactive effects of plant sterols and fish oil n-3 long-chain polyunsaturated fatty acids on the plasma lipid profile of mildly hyperlipidaemic Indian adults 2009 · Plant sterol-enriched yoghurt drink and control capsules · Adults aged 35–55 years with mild hypercholesterolaemia | 2 g | 4 weeks | — |
| Plant sterols from rapeseed and tall oils: effects on lipids, fat-soluble vitamins and plant sterol concentrations 2010 · Tall oil sterol margarine · Hypercholesterolemic subjects; age and sex not specified | 2 g | 4 weeks | — |
| Plant sterols from rapeseed and tall oils: effects on lipids, fat-soluble vitamins and plant sterol concentrations 2010 · Rapeseed sterol margarine · Hypercholesterolemic subjects; age and sex not specified | 2 g | 4 weeks | — |
| Evaluation of cardiovascular risk and oxidative stress parameters in hypercholesterolemic subjects on a standard healthy diet including low-fat milk enriched with plant sterols 2010 · diet+PS group · Hypercholesterolemic subjects; age and sex not reported | 2 g | 90 days | — |
| Phytosterols supplementation decreases plasma small and dense LDL levels in metabolic syndrome patients on a westernized type diet 2012 · plant sterol-enriched yogurt mini drink group · Patients with metabolic syndrome; age and sex not specified | 4 g | 60 days | — |
| Effects of plant sterol esters in skimmed milk and vegetable-fat-enriched milk on serum lipids and non-cholesterol sterols in hypercholesterolaemic subjects: a randomised, placebo-controlled, crossover study 2012 · PS-SM · Hypercholesterolaemic individuals with LDL-C >1300 mg/l; age and sex not stated | 2 g | 4 weeks | — |
| Effects of plant sterol esters in skimmed milk and vegetable-fat-enriched milk on serum lipids and non-cholesterol sterols in hypercholesterolaemic subjects: a randomised, placebo-controlled, crossover study 2012 · PS-VFM · Hypercholesterolaemic individuals with LDL-C >1300 mg/l; age and sex not stated | 2 g | 4 weeks | — |
| Reduction of LDL-cholesterol in mildly hypercholesterolemic Thais with plant stanol ester-fortified soy milk 2011 · stanol group · Thai adults with mild hypercholesterolemia; age and sex not specified | 2 g | 6 weeks | — |
| [Risk management of cardiovascular disease through milk enriched with sterols in a young-adult population; randomized controlled clinical trial] 2014 · milk with sterols · young adults; age and specific health condition not reported | 2.24 g | 3 weeks | — |
| Lipidomic changes of LDL in overweight and moderately hypercholesterolemic subjects taking phytosterol- and omega-3-supplemented milk 2015 · PhyS-milk · Overweight and moderately hypercholesterolemic subjects; age and sex not specified | 1.57 g | 4 weeks | — |
| A Randomized Open-Label Trial to Assess the Effect of Plant Sterols Associated with Ezetimibe in Low-Density Lipoprotein Levels in Patients with Coronary Artery Disease on Statin Therapy 2017 · plant sterol (PS) group · Patients with stable coronary artery disease, LDL >70 mg/dL, receiving statin therapy | 2 g | 6 weeks | — |
| A Randomized Open-Label Trial to Assess the Effect of Plant Sterols Associated with Ezetimibe in Low-Density Lipoprotein Levels in Patients with Coronary Artery Disease on Statin Therapy 2017 · ezetimibe+PS (EZ+PS) group · Patients with stable coronary artery disease, LDL >70 mg/dL, receiving statin therapy | 2 g | 6 weeks | — |
| Effect of dietary cholesterol and plant sterol consumption on plasma lipid responsiveness and cholesterol trafficking in healthy individuals 2017 · plant sterols · Healthy individuals from a Manitoba Hutterite population | 2 g | 4 weeks | — |
| Bread enriched with phytosterols with or without curcumin modulates lipoprotein profiles in hypercholesterolaemic individuals. A randomised controlled trial 2019 · PS · People with hypercholesterolaemia; age and sex not reported | 2.3 g | 4 weeks | — |
| Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment 1993 · sitostanol ester treatment · modestly hypercholesterolemic subjects with different apoE phenotypes | 3.4 g | 6 weeks | — |
| Effect of phytosterols and inulin-enriched soymilk on LDL-cholesterol in Thai subjects: a double-blinded randomized controlled trial 2015 · Study group (phytosterols and inulin-enriched soymilk) · Adults aged 18 years or older with LDL cholesterol of at least 130 mg/dL; statin-naïve and without diabetes or established cardiovascular disease | 2 g | 8 weeks | 120 |
| Simultaneous intake of beta-glucan and plant stanol esters affects lipid metabolism in slightly hypercholesterolemic subjects 2007 · combination muesli · mildly hypercholesterolemic men and women | 1.5 g | 4 weeks | 40 |
| A combination therapy including psyllium and plant sterols lowers LDL cholesterol by modifying lipoprotein metabolism in hypercholesterolemic individuals 2006 · treatment cookies (PSY+PS) · Healthy adults aged 35–65 years, male and female, with BMI 25–35 kg/m² and LDL cholesterol 2.6–4.1 mmol/L | 2.6 g | 4 weeks | 33 |
| A combination of psyllium and plant sterols alters lipoprotein metabolism in hypercholesterolemic subjects by modifying the intravascular processing of lipoproteins and increasing LDL uptake 2007 · PSY+PS test-cookie period · Hypercholesterolemic individuals; age and sex not stated | 2 g | 30 days | 33 |
| Cocoa, hazelnuts, sterols and soluble fiber cream reduces lipids and inflammation biomarkers in hypertensive patients: a randomized controlled trial 2012 · Product LMN (cocoa+hazelnuts+phytosterols+soluble fiber cream) · Men and women older than 20 with prehypertension or stage-1 hypertension, LDL cholesterol 3.35–4.88 mmol/L, and at least one cardiovascular risk factor | 2 g | 4 weeks | 27 |
| Ile-Pro-Pro and Val-Pro-Pro tripeptide-containing milk product has acute blood pressure lowering effects in mildly hypertensive subjects 2011 · Study product · Adults with untreated mild hypertension | 2 g | 1 day | 25 |
| Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial 2017 · Colesia™ active treatment · Adults aged 35–69 with polygenic hypercholesterolemia resistant to a Mediterranean diet | 800 mg | 8 weeks | 25 |
| Food products containing free tall oil-based phytosterols and oat beta-glucan lower serum total and LDL cholesterol in hypercholesterolemic adults 2003 · TOP/beta-glucan treatment · Adults with mild-to-moderate hypercholesterolemia | 1.8 g | 6 weeks | — |
| Fat-free foods supplemented with soy stanol-lecithin powder reduce cholesterol absorption and LDL cholesterol 2003 · Formulated soy stanols in a lemonade-flavored beverage · Normal or mildly hypercholesterolemic adults; mean age 50.6 years; 16 women and 8 men enrolled in the lipid-reduction study | 1.9 g | 4 weeks | — |
| Phytostanol tablets reduce human LDL-cholesterol 2005 · rapidly disintegrating stanol lecithin tablets · Human subjects; age, sex, and health status not specified | 1.26 g | 6 weeks | — |
| A spread containing bioactive milk peptides Ile-Pro-Pro and Val-Pro-Pro, and plant sterols has antihypertensive and cholesterol-lowering effects 2012 · Active spread group · Middle-aged adults with hypertension and hypercholesterolemia | 2 g | 10 weeks | — |
| Phytosterols, red yeast rice, and lifestyle changes instead of statins: a randomized, double-blinded, placebo-controlled trial 2013 · Red yeast rice plus phytosterol tablets · Adults with a history of statin refusal or statin-associated myalgias | 1.8 g | 52 weeks | — |
| Effect of fermented milk product containing lactotripeptides and plant sterol esters on haemodynamics in subjects with the metabolic syndrome--a randomised, double-blind, placebo-controlled study 2015 · 5 mg/d LTP and 2 g/d plant sterols · Subjects with metabolic syndrome; age and sex not specified | 2 g | 12 weeks | — |
| Effect of fermented milk product containing lactotripeptides and plant sterol esters on haemodynamics in subjects with the metabolic syndrome--a randomised, double-blind, placebo-controlled study 2015 · 25 mg/d LTP and 2 g/d plant sterols · Subjects with metabolic syndrome; age and sex not specified | 2 g | 12 weeks | — |
| Bread enriched with phytosterols with or without curcumin modulates lipoprotein profiles in hypercholesterolaemic individuals. A randomised controlled trial 2019 · PS-CC · People with hypercholesterolaemia; age and sex not reported | 2.3 g | 4 weeks | — |
| The Effect of Dietary Supplementation with Plant Sterols on Total and LDL-Cholesterol in Plasma Is Affected by Adherence to Mediterranean Diet: Insights from the DESCO Randomized Clinical Study 2023 · Phytosterol treatment · Italian adults aged 20–65 with polygenic, mild-to-moderate hypercholesterolemia | 2.5 g | 3 weeks | — |
| A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO(®)) on LDL Cholesterol Levels and Lipid Pattern in Subjects with Sub-Optimal Blood Cholesterol Levels (NATCOL Study) 2020 · LEVELIP DUO® · Adults aged 30–75 with moderately hypercholesterolemic, sub-optimal blood cholesterol levels, without other cardiovascular risk factors and not taking lipid-lowering drugs | 800 mg | 8 weeks | 43 |
| Fish-oil esters of plant sterols differ from vegetable-oil sterol esters in triglycerides lowering, carotenoid bioavailability and impact on plasminogen activator inhibitor-1 (PAI-1) concentrations in hypercholesterolemic subjects 2007 · PS-FO · Men and postmenopausal women aged 30–65 years with mildly overweight hypercholesterolemia | 1.7 g | 4 weeks | 21 |
| Effects of a Novel Nutraceutical Combination (Aquilea Colesterol(®)) on the Lipid Profile and Inflammatory Biomarkers: A Randomized Control Trial 2019 · nutraceutical combination group · Men and women aged 35–75 with primary hypercholesterolemia and low-to-moderate cardiovascular risk | 1.5 g | 90 days | 20 |
| Reduction in Serum LDL Cholesterol Using a Nutrient Compendium in Hyperlipidemic Adults Unable or Unwilling to Use Statin Therapy: A Double-Blind Randomized Crossover Clinical Trial 2022 · Treatment foods · Adult men and women with hyperlipidemia who were unable or unwilling to use statin therapy | 2 g | 4 weeks | — |
| An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations 2002 · sterol ester-1 · Hypercholesterolemic free-living adults; age and sex not specified | 2.3 g | 3 weeks | 46 |
| An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations 2002 · stanol ester-1 · Hypercholesterolemic free-living adults; age and sex not specified | 2.5 g | 3 weeks | 46 |
| Plasma biomarker of dietary phytosterol intake 2015 · 400 mg phytosterols/day · Adults; mean age 60.0 years; no specific condition stated | 400 mg | 4 weeks | 18 |
| Plasma biomarker of dietary phytosterol intake 2015 · 2000 mg phytosterols/day · Adults; mean age 60.0 years; no specific condition stated | 2 g | 4 weeks | 18 |
| Similar serum plant sterol responses of human subjects heterozygous for a mutation causing sitosterolemia and controls to diets enriched in plant sterols or stanols 2007 · plant sterol margarine · Adults: 7 heterozygous relatives of sitosterolemia patients and 10 controls; ages and sex not stated. | 2 g | 6 weeks | 17 |
| Similar serum plant sterol responses of human subjects heterozygous for a mutation causing sitosterolemia and controls to diets enriched in plant sterols or stanols 2007 · stanol-enriched margarine · Adults: 7 heterozygous relatives of sitosterolemia patients and 10 controls; ages and sex not stated. | 2 g | 6 weeks | 17 |
| Increases in plasma plant sterols stabilize within four weeks of plant sterol intake and are independent of cholesterol metabolism 2016 · PS group · Hypercholesterolemic but otherwise healthy men and women; age range not reported | 3 g | 12 weeks | — |
| Effects of Daily Consumption of an Aqueous Dispersion of Free-Phytosterols Nanoparticles on Individuals with Metabolic Syndrome: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial 2020 · phytosterol group · Adults aged 18–65 with metabolic syndrome | 2 g | 24 weeks | 109 |
| Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet 2001 · low-sterol group · Adults with mild-to-moderate primary hypercholesterolemia | 1.1 g | 5 weeks | 92 |
| Apolipoprotein E polymorphism and serum lipid response to plant sterols in humans 2002 · sterol-enriched margarine · Healthy adults, mean age 25 years, with E3/3, E3/4 or E4/4 apolipoprotein E genotypes | 3.2 g | 3 weeks | 88 |
| Plant stanol ester margarine lowers serum total and low-density lipoprotein cholesterol concentrations of healthy children: the STRIP project. Special Turku Coronary Risk Factors Intervention Project 2000 · plant stanol ester margarine · Healthy 6-year-old children already consuming a low-saturated-fat, low-cholesterol diet | 1.5 g | 90 days | 81 |
| Plant sterols lower LDL-cholesterol and triglycerides in dyslipidemic individuals with or at risk of developing type 2 diabetes; a randomized, double-blind, placebo-controlled study 2018 · PS intervention · Adults aged 30–75 with dyslipidemia and elevated triglycerides, either at high risk of developing type 2 diabetes or with established, controlled type 2 diabetes | 2.2 g | 6 weeks | 68 |
| The human cholesteryl ester transfer protein I405V polymorphism is associated with plasma cholesterol concentration and its reduction by dietary phytosterol esters 2003 · PSE · Adults aged 20–60 with moderate primary hypercholesterolemia; 50 women and 10 men | 2.8 g | 4 weeks | 60 |
| Increased intake of fruit and vegetables and a low-fat diet, with and without low-fat plant sterol-enriched spread consumption: effects on plasma lipoprotein and carotenoid metabolism 2004 · PSE-enriched spread · Hypercholesterolaemic men | 21 g | 3 weeks | 48 |
| Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study 2015 · plant stanol group · Normo- to moderately hypercholesterolaemic, non-obese adults; 35 men and 57 women overall | 3 g | 26 weeks | 46 |
| Serum lipid responses to phytosterol-enriched milk in a moderate hypercholesterolemic population is not affected by apolipoprotein E polymorphism or diameter of low-density lipoprotein particles 2011 · diet+PS group · Mildly hypercholesterolemic subjects; age and sex not specified | 2 g | 90 days | 41 |
| Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet 2001 · high-sterol group · Adults with mild-to-moderate primary hypercholesterolemia | 2.2 g | 5 weeks | 40 |
| Efficacy of yogurt drink with added plant stanol esters (Benecol®, Colanta) in reducing total and LDL cholesterol in subjects with moderate hypercholesterolemia: a randomized placebo-controlled crossover trial NCT01461798 2014 · Benecol yogurt drink with plant stanols as esters · Adults aged 25–50 with moderate hypercholesterolemia | 4 g | 4 weeks | 40 |
| A positive impact on the serum lipid profile and cytokines after the consumption of a plant sterol-enriched beverage with a milk fat globule membrane: a clinical study 2018 · PS-added beverage · Postmenopausal women | 2 g | 6 weeks | 38 |
| Phytosterols Supplementation Reduces Endothelin-1 Plasma Concentration in Moderately Hypercholesterolemic Individuals Independently of Their Cholesterol-Lowering Properties 2020 · phytosterol group · Adults aged 38–77 with moderate hypercholesterolemia | 3.2 g | 4 weeks | 38 |
| Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes 2006 · plant sterols · Adults aged 38–74 years, mildly hypercholesterolemic, with or without type II diabetes | 1.8 g | 3 weeks | 34 |
| Cocoa flavanol-enriched snack bars containing phytosterols effectively lower total and low-density lipoprotein cholesterol levels 2006 · cocoa flavanol-enriched snack bar containing phytosterol · people with hypercholesterolemia; age and sex not reported | 3 g | 6 weeks | 32 |
| Cocoa flavanol-enriched snack bars containing phytosterols effectively lower total and low-density lipoprotein cholesterol levels 2006 · cocoa flavanol-enriched snack bar containing phytosterol · people with hypercholesterolemia; age and sex not reported | 3 g | 6 weeks | 32 |
| Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study 2017 · PhyS-supplemented milk · Healthy adults aged 25–70 with overweight or grade 1 obesity (BMI 25–35) | 1.6 g | 4 weeks | 32 |
| Effects of yoghurt enriched with plant sterols on serum lipids in patients with moderate hypercholesterolaemia 2001 · 1 g plant sterol group · Patients with primary moderate hypercholesterolaemia | 1 g | 4 weeks | 30 |
| A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial 2019 · PS group · Adults aged 51–65 with impaired glucose regulation | 1.7 g | 12 weeks | 30 |
| Dietary plant stanol ester consumption improves immune function in asthma patients: results of a randomized, double-blind clinical trial 2016 · plant stanol ester group · asthma patients; age and sex not reported | 4 g | 8 weeks | 29 |
| Cholesterol-lowering efficacy of plant sterols in low-fat yogurt consumed as a snack or with a meal 2008 · single PS dose consumed with a meal · Adults with hyperlipidemia; male and female participants | 1.6 g | 4 weeks | 26 |
| Cholesterol-lowering efficacy of plant sterols in low-fat yogurt consumed as a snack or with a meal 2008 · single PS dose as an afternoon snack · Adults with hyperlipidemia; male and female participants | 1.6 g | 4 weeks | 26 |
| Plant sterols-enriched diet decreases small, dense LDL-cholesterol levels in children with hypercholesterolemia: a prospective study 2014 · Hypercholesterolemic group · Children and adolescents aged 4.5–16 years with hypercholesterolemia | 2 g | 1 year | 25 |
| Safety and tolerability of esterified phytosterols administered in reduced-fat spread and salad dressing to healthy adult men and women 2001 · 9.0 g/day phytosterols · Healthy free-living adult men and women | 9 g | 8 weeks | 23 |
| Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner 2000 · 0.8 g/d plant stanol ester · Men and women with hypercholesterolemia; age range not reported | 800 mg | 4 weeks | 22 |
| Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner 2000 · 1.6 g/d plant stanol ester · Men and women with hypercholesterolemia; age range not reported | 1.6 g | 4 weeks | 22 |
| Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner 2000 · 2.3 g/d actual plant stanol ester intake (target 2.4 g/d) · Men and women with hypercholesterolemia; age range not reported | 2.3 g | 4 weeks | 22 |
| Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner 2000 · 3.0 g/d actual plant stanol ester intake (target 3.2 g/d) · Men and women with hypercholesterolemia; age range not reported | 3 g | 4 weeks | 22 |
| Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine: women and dietary sitostanol 1997 · Sitostanol ester margarine, crossover study · Postmenopausal women with angiographically documented coronary artery disease and a previous myocardial infarction | 3 g | 7 weeks | 22 |
| Short-term administration of tall oil phytosterols improves plasma lipid profiles in subjects with different cholesterol levels 1998 · tall oil phytosterol treatment · 22 subjects with different cholesterol levels | 21.2 mg/kg | 10 days | 22 |
| Safety and tolerability of esterified phytosterols administered in reduced-fat spread and salad dressing to healthy adult men and women 2001 · 3.0 g/day phytosterols · Healthy free-living adult men and women | 3 g | 8 weeks | 21 |
| [Minimal effective dose on serum cholesterol concentration and the safety evaluation of dressing containing plant sterol in Japanese subjects] 2008 · 2400 mg/day plant sterol group (Experiment 2) · Healthy Japanese adults with total cholesterol ≥180 mg/dL, 10 men and 11 women | 2.4 g | 4 weeks | 21 |
| Effects of high adherence to mediterranean or low-fat diets in medicated secondary prevention patients 2011 · TLCD · Men aged 45–65 with coronary artery disease and a prior coronary event | 20 g | 90 days | 21 |
| Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy 2010 · cholestyramine plus sitosterol · Hypercholesterolemic patients eligible for carotid endarterectomy | 2.5 g | 90 days | 20 |
| Serum and lipoprotein sitostanol and non-cholesterol sterols after an acute dose of plant stanol ester on its long-term consumption 2012 · intervention group · Adults with hypercholesterolemia; age and sex not stated | 8.8 g | 10 weeks | 20 |
| Impact of colonic fermentation on sterols after the intake of a plant sterol-enriched beverage: A randomized, double-blind crossover trial 2019 · PS-enriched beverage · Postmenopausal women with mild hypercholesterolemia | 2 g | 6 weeks | 20 |
| Safety and tolerability of esterified phytosterols administered in reduced-fat spread and salad dressing to healthy adult men and women 2001 · 6.0 g/day phytosterols · Healthy free-living adult men and women | 6 g | 8 weeks | 19 |
| Plant sterol-enriched soy milk consumption modulates 5-lipoxygenase, 12-lipoxygenase, and myeloperoxidase activities in healthy adults - a randomized-controlled trial 2016 · plant sterols treatment · Healthy adults; mean age 35.3 years; 67% female | 2 g | 4 weeks | 18 |
| Dietary Plant Sterols Supplementation Increases In Vivo Nitrite and Nitrate Production in Healthy Adults: A Randomized, Controlled Study 2017 · Plant sterols-enriched soy milk powder · Healthy adults aged over 21 years; Asian ethnicities; no stated cardiovascular-related disease | 2 g | 4 weeks | 18 |
| High molecular weight oat β-glucan enhances lipid-lowering effects of phytosterols. A randomised controlled trial 2020 · PS · Hypercholesterolaemic individuals; age and sex not stated | 2 g | 6 weeks | 18 |
| Blood lipid responses to plant stanol ester supplementation and aerobic exercise training 2006 · PSE group · Healthy sedentary middle-aged men and postmenopausal women, age 53 ± 8 years | 3 g | 9 weeks | 17 |
| Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial 2018 · phytosterols (PS) · Hypercholesterolaemic individuals; age range and sex not reported | 2 g | 4 weeks | 17 |
| Non-esterified plant sterols solubilized in low fat milks inhibit cholesterol absorption--a stable isotope double-blind crossover study 2003 · plant sterol milk · adult men with hypercholesterolemia | 1.8 g | 6 days | 16 |
| Plant sterol ester diet supplementation increases serum plant sterols and markers of cholesterol synthesis, but has no effect on total cholesterol levels 2017 · Plant sterol ester supplemented margarine · Healthy volunteers, average age 34 years, with no or mild hypercholesterolemia | 3 g | 4 weeks | 16 |
| Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters 2000 · margarine with phytosterol esters (MSE) · 15 hypercholesterolemic subjects; age and sex not specified | 1.84 g | 3 weeks | 15 |
| Plant sterol or stanol consumption does not affect erythrocyte osmotic fragility in patients on statin treatment 2006 · plant sterol ester-enriched margarine · Adults receiving stable statin treatment with already increased serum plant sterol and stanol concentrations | 2.5 g | 16 weeks | 15 |
| Plant sterol or stanol consumption does not affect erythrocyte osmotic fragility in patients on statin treatment 2006 · plant stanol ester-enriched margarine · Adults receiving stable statin treatment with already increased serum plant sterol and stanol concentrations | 2.5 g | 16 weeks | 15 |
| Combining Plant Sterols With Walking Lowers Postprandial Triacylglycerol More Than Walking Only in Chinese Men With Elevated Body Mass Index 2019 · PS-S · Chinese men aged about 25 years with elevated BMI (≥23.5 kg/m²) | 2 g | 10 days | 15 |
| Combining Plant Sterols With Walking Lowers Postprandial Triacylglycerol More Than Walking Only in Chinese Men With Elevated Body Mass Index 2019 · PS-W · Chinese men aged about 25 years with elevated BMI (≥23.5 kg/m²) | 2 g | 10 days | 15 |
| Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic syndrome 2011 · diet + PS · Adults with moderate hypercholesterolaemia and metabolic syndrome; age and sex not specified | 2 g | 90 days | 14 |
| An acute intake of plant stanol esters alters immune-related pathways in the jejunum of healthy volunteers 2015 · plant stanol ester condition · Healthy adults aged 21–55 years, eight female and six male | 4 g | 1 day | 14 |
| Effects of plant stanol ester consumption on fasting plasma oxy(phyto)sterol concentrations as related to fecal microbiota characteristics 2017 · plant stanol ester enriched margarine · healthy subjects; age and sex not reported | 3 g | 3 weeks | 13 |
| Safety evaluation of phytosterol esters. Part 4. Faecal concentrations of bile acids and neutral sterols in healthy normolipidaemic volunteers consuming a controlled diet either with or without a phytosterol ester-enriched margarine 1999 · phytosterol ester-enriched margarine · Healthy adult males and females; mean age 36 years | 8.6 g | 4 weeks | 12 |
| Safety evaluation of phytosterol esters. Part 5. Faecal short-chain fatty acid and microflora content, faecal bacterial enzyme activity and serum female sex hormones in healthy normolipidaemic volunteers consuming a controlled diet either with or without a phytosterol ester-enriched margarine 1999 · test margarine · Healthy normolipidaemic men and women, mean age 36 years; women had regular menstrual cycles | 8.6 g | 4 weeks | 12 |
| Effects of yoghurt enriched with free plant sterols on the levels of serum lipids and plant sterols in moderately hypercholesterolaemic subjects on a high-fat diet 2008 · Study II sterol group · Moderately hypercholesterolaemic subjects on a high-fat diet; age and sex not reported | 2 g | 8 weeks | 12 |
| A diet moderately enriched in phytosterols lowers plasma cholesterol concentrations in normocholesterolemic humans 1995 · phytosterols period · healthy normolipidic adults; age and sex not specified | 740 mg | 4 weeks | 12 |
| Effects of yoghurt enriched with plant sterols on serum lipids in patients with moderate hypercholesterolaemia 2001 · 2 g plant sterols group · Patients with primary moderate hypercholesterolaemia | 2 g | 8 weeks | 11 |
| Effects of plant stanol esters on serum cholesterol concentrations, relative markers of cholesterol metabolism and endothelial function in type 1 diabetes 2008 · intervention group · People with type 1 diabetes; age and sex not specified | 2 g | 12 weeks | 11 |
| Non-cholesterol sterols in serum and endarterectomized carotid arteries after a short-term plant stanol and sterol ester challenge 2011 · steest · Elderly statin-treated asymptomatic patients undergoing carotid endarterectomy | 2 g | 4 weeks | 11 |
| Effects of long term plant sterol and -stanol consumption on the retinal vasculature: a randomized controlled trial in statin users 2011 · Plant sterol enriched margarine · Statin users; age and sex not reported | 2.5 g | 85 weeks | 11 |
| Phytosterols that are naturally present in commercial corn oil significantly reduce cholesterol absorption in humans 2002 · Sterol-free corn oil with 300 mg phytosterols added back · Healthy subjects; age and sex not stated | 300 mg | 1 day | 10 |
| Recommended or high daily intakes of plant stanol esters do not affect ex vivo T-cell derived cytokine production in immunologically healthy volunteers 2024 · Plant stanols 2.5 g/d · Otherwise healthy adults aged 18–65 with hypertriglyceridemia; selected participants had BMI <27 kg/m² and no self-reported asthma, allergies, eczema, or inflammatory disease | 2.5 g | 3 weeks | 10 |
| Recommended or high daily intakes of plant stanol esters do not affect ex vivo T-cell derived cytokine production in immunologically healthy volunteers 2024 · Plant stanols 9.0 g/d · Healthy adults aged 18–65 with slightly elevated total cholesterol; selected participants had BMI <27 kg/m² and no self-reported asthma, allergies, eczema, or inflammatory disease | 9 g | 4 weeks | 10 |
| Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine: women and dietary sitostanol 1997 · Sitostanol ester margarine with simvastatin · Postmenopausal women with a previous myocardial infarction taking simvastatin | 3 g | 12 weeks | 10 |
| A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients 2009 · placebo + stanol drink · Adults with metabolic syndrome | 2 g | 9 weeks | 9 |
| Plant stanol esters lower serum triacylglycerol concentrations via a reduced hepatic VLDL-1 production 2009 · Plant stanols (metabolic syndrome subjects) · Adults with metabolic syndrome; mean age 60 years; men and women | 2 g | 8 weeks | 9 |
| A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients 2009 · simvastatin + stanol drink · Adults with metabolic syndrome | 2 g | 9 weeks | 8 |
| Effects of long term plant sterol and -stanol consumption on the retinal vasculature: a randomized controlled trial in statin users 2011 · Plant stanol enriched margarine · Statin users; age and sex not reported | 2.5 g | 85 weeks | 8 |
| Soy sterol esters and beta-sitostanol ester as inhibitors of cholesterol absorption in human small bowel 2000 · soy sterol ester period · Seven ileostomy subjects; age and sex not reported | 1.5 g | — | 7 |
| Soy sterol esters and beta-sitostanol ester as inhibitors of cholesterol absorption in human small bowel 2000 · beta-sitostanol ester period · Seven ileostomy subjects; age and sex not reported | 1.5 g | — | 7 |
| Nonesterified phytosterols dissolved and recrystallized in oil reduce plasma cholesterol in gerbils and humans 2004 · phytosterol-enriched tortilla chips · 7 human subjects; age, sex, and health condition not reported | 1.5 g | 4 weeks | 7 |
| Phytosterols that are naturally present in commercial corn oil significantly reduce cholesterol absorption in humans 2002 · Sterol-free corn oil with 150 mg phytosterols added back · Healthy subjects; age and sex not stated | 150 mg | 1 day | 5 |
| Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects 1999 · wood stanol ester-containing margarine (WSEM) · Hypercholesterolemic subjects; age and sex not specified | 2.31 g | 8 weeks | — |
| Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects 1999 · vegetable oil stanol ester-containing margarine (VOSEM) · Hypercholesterolemic subjects; age and sex not specified | 2.16 g | 8 weeks | — |
| Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects 1999 · Spread with 0.83 g/d plant sterols · Apparently healthy normocholesterolaemic and mildly hypercholesterolaemic volunteers | 830 mg | 25 days | — |
| Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects 1999 · Spread with 1.61 g/d plant sterols · Apparently healthy normocholesterolaemic and mildly hypercholesterolaemic volunteers | 1.61 g | 25 days | — |
| Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects 1999 · Spread with 3.24 g/d plant sterols · Apparently healthy normocholesterolaemic and mildly hypercholesterolaemic volunteers | 3.24 g | 25 days | — |
| Sitostanol administered in lecithin micelles potently reduces cholesterol absorption in humans 1999 · Sitostanol powder · Six healthy adults; age and sex not reported | 1 g | 1 day | — |
| Cholesterol-lowering effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial 1999 · EU 3 G · Adults with mildly elevated cholesterol; men and women | 3 g | 8 weeks | — |
| Cholesterol-lowering effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial 1999 · US 3 G · Adults with mildly elevated cholesterol; men and women | 3 g | 8 weeks | — |
| Cholesterol-lowering effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial 1999 · US 2 G · Adults with mildly elevated cholesterol; men and women | 2.01 g | 8 weeks | — |
| Effects of low-fat stanol ester enriched margarines on concentrations of serum carotenoids in subjects with elevated serum cholesterol concentrations 1999 · WSEM group · Hypercholesterolaemic subjects; age and sex not stated | 2.31 g | 8 weeks | — |
| Effects of low-fat stanol ester enriched margarines on concentrations of serum carotenoids in subjects with elevated serum cholesterol concentrations 1999 · VOSEM group · Hypercholesterolaemic subjects; age and sex not stated | 2.16 g | 8 weeks | — |
| Plant stanol ester and bran fiber in childhood: effects on lipids, stool weight and stool frequency in preschool children 1999 · Diet Phase A (plant stanol ester) · Healthy children aged 2–5 years | 3 g | 4 weeks | — |
| Spreads enriched with plant sterols, either esterified 4,4-dimethylsterols or free 4-desmethylsterols, and plasma total- and LDL-cholesterol concentrations 1999 · Spread enriched with free soyabean-oil sterols · Healthy adults, average age 44 years, with baseline plasma total cholesterol below 8 mmol/L | 800 mg | 3 weeks | — |
| Spreads enriched with plant sterols, either esterified 4,4-dimethylsterols or free 4-desmethylsterols, and plasma total- and LDL-cholesterol concentrations 1999 · Spread enriched with sheanut-oil sterols · Healthy adults, average age 44 years, with baseline plasma total cholesterol below 8 mmol/L | 3.3 g | 3 weeks | — |
| Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet 2000 · STAEST-enriched margarine · Hypercholesterolaemic subjects on a low-fat diet; age range and sex not specified | 2.01 g | 4 weeks | — |
| Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet 2000 · STEEST-enriched margarine · Hypercholesterolaemic subjects on a low-fat diet; age range and sex not specified | 2.01 g | 4 weeks | — |
| Effect of plant sterols from rice bran oil and triterpene alcohols from sheanut oil on serum lipoprotein concentrations in humans 2000 · plant sterols from rice bran oil · healthy, normolipemic adult men and women | 2.1 g | 3 weeks | — |
| Solubilization of phytosterols in diacylglycerol versus triacylglycerol improves the serum cholesterol-lowering effect 2001 · Mayonnaise containing PS dissolved in DG (PS/DG) · Healthy men aged 29–50 years who were normocholesterolemic or moderately hypercholesterolemic | 500 mg | 2 weeks | — |
| Solubilization of phytosterols in diacylglycerol versus triacylglycerol improves the serum cholesterol-lowering effect 2001 · Mayonnaise containing PS dispersed in TG (PS/TG) · Healthy men aged 29–50 years who were normocholesterolemic or moderately hypercholesterolemic | 500 mg | 2 weeks | — |
| Effects of a plant sterol-enriched spread on serum lipids and lipoproteins in mildly hypercholesterolaemic subjects 2002 · Plant sterol-enriched spread · Healthy adult men and women, average age 55 years, with mildly elevated serum cholesterol | 2 g | 4 weeks | — |
| A single daily dose of soybean phytosterols in ground beef decreases serum total cholesterol and LDL cholesterol in young, mildly hypercholesterolemic men 2002 · treatment group · Male college students with mildly elevated plasma total and LDL cholesterol; age range not stated | 2.7 g | 4 weeks | — |
| Consumption of tall oil-derived phytosterols in a chocolate matrix significantly decreases plasma total and low-density lipoprotein-cholesterol levels 2002 · phytosterol-enriched chocolate · Adults with primary hypercholesterolaemia and total cholesterol below 8 mmol/L | 1.8 g | 4 weeks | — |
| Plant sterol-enriched spread enhances the cholesterol-lowering potential of a fat-reduced diet 2003 · polyunsaturated spread containing plant sterols · Free-living men and women, mean age 46.7 years, with moderately elevated plasma total cholesterol | 2 g | 4 weeks | — |
| Effects of phytosterol ester-enriched vegetable oil on plasma lipoproteins in healthy men 2003 · phytosterol ester-enriched vegetable oil · Healthy men with slightly elevated total cholesterol concentration | 450 mg | 12 weeks | — |
| Cholesterol-lowering effects of plant sterol esters differ in milk, yoghurt, bread and cereal 2004 · milk · Free-living men and women, mean age 54 years, with moderately elevated plasma total cholesterol | 1.6 g | 3 weeks | — |
| Cholesterol-lowering effects of plant sterol esters differ in milk, yoghurt, bread and cereal 2004 · yoghurt · Free-living men and women, mean age 54 years, with moderately elevated plasma total cholesterol | 1.6 g | 3 weeks | — |
| Unesterified plant sterols and stanols do not affect LDL electrophoretic characteristics in hypercholesterolemic subjects 2004 · plant sterols (S) · Healthy hypercholesterolemic subjects; age and sex not specified | 1.8 g | — | — |
| Unesterified plant sterols and stanols do not affect LDL electrophoretic characteristics in hypercholesterolemic subjects 2004 · plant stanols (SN) · Healthy hypercholesterolemic subjects; age and sex not specified | 1.8 g | — | — |
| Both free and esterified plant sterols reduce cholesterol absorption and the bioavailability of beta-carotene and alpha-tocopherol in normocholesterolemic humans 2004 · beverage supplemented with free plant sterols · Normocholesterolemic men | 2.2 g | 7 days | — |
| Both free and esterified plant sterols reduce cholesterol absorption and the bioavailability of beta-carotene and alpha-tocopherol in normocholesterolemic humans 2004 · beverage supplemented with sterol esters · Normocholesterolemic men | 2.2 g | 7 days | — |
| Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects 2005 · PSteE-milk · Adults with modest hypercholesterolemia (total cholesterol 5–7.5 mmol/L) | 2 g | 3 weeks | — |
| Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects 2005 · PSteE-yoghurt · Adults with modest hypercholesterolemia (total cholesterol 5–7.5 mmol/L) | 1.8 g | 3 weeks | — |
| Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects 2005 · PStaE-yoghurt · Adults with modest hypercholesterolemia (total cholesterol 5–7.5 mmol/L) | 1.7 g | 3 weeks | — |
| Safety aspects and cholesterol-lowering efficacy of low fat dairy products containing plant sterols 2006 · plant sterol group · Mildly or moderately hypercholesterolaemic subjects; age and sex not reported | 2 g | 6 weeks | — |
| Phytosterol and phytostanol esters are effectively hydrolysed in the gut and do not affect fat digestion in ileostomy subjects 2006 · PSTE intervention period · Ileostomy subjects; age and sex not reported | 2.5 g | — | — |
| Phytosterol and phytostanol esters are effectively hydrolysed in the gut and do not affect fat digestion in ileostomy subjects 2006 · PSTA intervention period · Ileostomy subjects; age and sex not reported | 2.5 g | — | — |
| Reduced-calorie orange juice beverage with plant sterols lowers C-reactive protein concentrations and improves the lipid profile in human volunteers 2006 · Sterol Bev · Healthy subjects; age and sex not specified | 2 g | 8 weeks | — |
| Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols 2006 · SU-PS · Moderately overweight, hyperlipidemic adults; age and sex not specified | 1.7 g | 4 weeks | — |
| Plant sterol-enriched milk tea decreases blood cholesterol concentrations in Chinese adults: a randomised controlled trial 2007 · 2.3 g plant sterol supplementation · Chinese adults; mean age 44 years; 62% female; 62% with a history of hypercholesterolaemia | 2.3 g | 5 weeks | — |
| Plant sterol-enriched milk tea decreases blood cholesterol concentrations in Chinese adults: a randomised controlled trial 2007 · 1.5 g plant sterol supplementation · Chinese adults; mean age 44 years; 62% female; 62% with a history of hypercholesterolaemia | 1.5 g | 5 weeks | — |
| Cholesterol-lowering ability of a phytostanol softgel supplement in adults with mild to moderate hypercholesterolemia 2006 · phytostanol supplementation · Adults with mild to moderate hypercholesterolemia | 1.6 g | 4 weeks | — |
| The effect of a combination of plant sterol-enriched foods in mildly hypercholesterolemic subjects 2007 · Plant sterol-enriched products · Mildly hypercholesterolemic adults; mean age 50.6 years | 2.3 g | 4 weeks | — |
| Baseline plasma plant sterol concentrations do not predict changes in serum lipids, C-reactive protein (CRP) and plasma plant sterols following intake of a plant sterol-enriched food 2009 · 2.0 g per day PS-enriched spread · Otherwise healthy hypercholesterolemic men, with high or low baseline plasma plant sterol concentrations | 2 g | 4 weeks | — |
| [Effects of dressing containing plant sterol on serum cholesterol concentration and the safety evaluation in borderline or mildly hypercholesterolemic Japanese subjects] 2008 · PS(+)-group · Japanese subjects with borderline or mildly elevated cholesterol | 800 mg | 12 weeks | — |
| The lipid-lowering effects of phytosterols and (n-3) polyunsaturated fatty acids are synergistic and complementary in hyperlipidemic men and women 2008 · Phytosterols alone · Men and women with hyperlipidemia; age range not reported | 2 g | 3 weeks | — |
| Serum lipid and antioxidant responses in hypercholesterolemic men and women receiving plant sterol esters vary by apolipoprotein E genotype 2009 · 1.1 g/d plant sterol ester spread · Hypercholesterolemic adults | 1.1 g | 5 weeks | — |
| Serum lipid and antioxidant responses in hypercholesterolemic men and women receiving plant sterol esters vary by apolipoprotein E genotype 2009 · 2.2 g/d plant sterol ester spread · Hypercholesterolemic adults | 2.2 g | 5 weeks | — |
| Plant stanol supplementation decreases serum triacylglycerols in subjects with overt hypertriglyceridemia 2009 · PSE-enriched margarine · Adults with elevated fasting triacylglycerol concentrations (>1.7 mmol/L) | 2.5 g | 3 weeks | — |
| Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors 2011 · plant stanol ester spread · Mildly hypercholesterolaemic subjects | 2 g | 120 days | — |
| Effect of orange juice and beverage with phytosterols on cytokines and PAI-1 activity 2011 · Sterol OJ · Healthy human volunteers | 2 g | 8 weeks | — |
| Effect of orange juice and beverage with phytosterols on cytokines and PAI-1 activity 2011 · Sterol OJBev · Healthy human volunteers | 2 g | 8 weeks | — |
| Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic syndrome 2011 · diet + PS · Adults with moderate hypercholesterolaemia without metabolic syndrome; age and sex not specified | 2 g | 90 days | — |
| Action of plant sterol intervention on sterol kinetics in hypercholesterolemic men with high versus low basal circulatory plant sterol concentrations 2011 · plant sterol (PS) intervention · hypercholesterolemic men; age range not reported | 2 g | 4 weeks | — |
| Effects of plant sterol- or stanol-enriched margarine on fasting plasma oxyphytosterol concentrations in healthy subjects 2013 · plant sterol-enriched margarine · Healthy adults aged 18–70 years | 3 g | 4 weeks | — |
| Effects of plant sterol- or stanol-enriched margarine on fasting plasma oxyphytosterol concentrations in healthy subjects 2013 · plant stanol-enriched margarine · Healthy adults aged 18–70 years | 3 g | 4 weeks | — |
| Effect of β-cryptoxanthin plus phytosterols on cardiovascular risk and bone turnover markers in post-menopausal women: a randomized crossover trial 2014 · PS · Post-menopausal women; age and health conditions not specified | 1.5 g | 4 weeks | — |
| Low doses of eicosapentaenoic acid and docosahexaenoic acid from fish oil dose-dependently decrease serum triglyceride concentrations in the presence of plant sterols in hypercholesterolemic men and women 2014 · Intervention spread with 0.0 g/d EPA+DHA · Hypercholesterolemic men and women aged 25–74 years | 2.5 g | 4 weeks | — |
| Effects of margarine enriched with plant sterol esters from rapeseed and tall oils on markers of endothelial function, inflammation and hemostasis 2015 · rapeseed-sterol margarine · Hypercholesterolemic volunteers; age and sex not specified | 2 g | 4 weeks | — |
| Effects of margarine enriched with plant sterol esters from rapeseed and tall oils on markers of endothelial function, inflammation and hemostasis 2015 · tall-sterol margarine · Hypercholesterolemic volunteers; age and sex not specified | 2 g | 4 weeks | — |
| The effect of plant sterols and different low doses of omega-3 fatty acids from fish oil on lipoprotein subclasses 2015 · PS (2.5 g/day) and EPA+DHA (0.0 g/day) spread · Hypercholesterolemic subjects; age and sex not specified | 2.5 g | 4 weeks | — |
| Soy milk powder supplemented with phytosterol esters reduced serum cholesterol level in hypercholesterolemia independently of lipoprotein E genotype: a random clinical placebo-controlled trial 2016 · PS esters-enriched soy milk powder group · Older Chinese adults with mild to moderate hyperlipidemia | 2 g | 26 weeks | — |
| Efecto de esteroles vegetales en la reducción del colesterol plasmático: ensayo clínico, controlado, aleatorizado, cruzado y doble ciego 2016 · experimental group · Adults aged 38.8 ± 7.3 years with hypercholesterolemia | 2.24 g | 3 weeks | — |
| Combined effect of n-3 fatty acids and phytosterol esters on alleviating hepatic steatosis in non-alcoholic fatty liver disease subjects: a double-blind placebo-controlled clinical trial 2020 · PS group · People with non-alcoholic fatty liver disease (NAFLD); age and sex not reported | 3.3 g | — | — |
| Plant Stanol Esters Reduce LDL (Low-Density Lipoprotein) Aggregation by Altering LDL Surface Lipids: The BLOOD FLOW Randomized Intervention Study 2020 · plant stanol ester-enriched spread · Study subjects; age, sex, and health condition not specified | 3 g | 26 weeks | — |
| Plant stanol consumption increases anti-COVID-19 antibody responses, independent of changes in serum cholesterol concentrations: a randomized controlled trial 2024 · plant stanol ester group · People with overweight or obesity receiving a COVID-19 vaccination | 4 g | 6 weeks | — |
| Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population 1995 · Margarine containing sitostanol ester, 1.8 g/day · People with mild hypercholesterolemia | 1.8 g | 1 year | — |
| Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population 1995 · Margarine containing sitostanol ester, 2.6 g/day · People with mild hypercholesterolemia | 2.6 g | 1 year | — |
| Effects of inhibiting cholesterol absorption and synthesis on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin-dependent diabetic men 1996 · sitostanol ester margarine · Men with non-insulin-dependent diabetes mellitus and mild hypercholesterolemia | 3 g | 7 weeks | — |
| Effects of inhibiting cholesterol absorption and synthesis on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin-dependent diabetic men 1996 · sitostanol ester margarine plus pravastatin · Men with non-insulin-dependent diabetes mellitus and mild hypercholesterolemia | 3 g | 7 weeks | — |
| Serum Concentration of Plant Sterol Oxidation Products (POP) Compared to Cholesterol Oxidation Products (COP) after Intake of Oxidized Plant Sterols: A Randomised, Placebo-Controlled, Double-Blind Dose‒Response Pilot Study 2019 · low-dose POP group · Healthy men and women aged 40–75 with screening total cholesterol 5.0–8.0 mmol/L | 2.3 g | 6 weeks | 15 |
| Serum Concentration of Plant Sterol Oxidation Products (POP) Compared to Cholesterol Oxidation Products (COP) after Intake of Oxidized Plant Sterols: A Randomised, Placebo-Controlled, Double-Blind Dose‒Response Pilot Study 2019 · medium-dose POP group · Healthy men and women aged 40–75 with screening total cholesterol 5.0–8.0 mmol/L | 1.8 g | 6 weeks | 15 |
| Gastrointestinal absorption and plasma kinetics of soy Delta(5)-phytosterols and phytostanols in humans 2002 · Delta(5)-soy sterol test meal · 10 healthy subjects | 600 mg | 1 day | 10 |
| Gastrointestinal absorption and plasma kinetics of soy Delta(5)-phytosterols and phytostanols in humans 2002 · Soy stanol test meal · 10 healthy subjects | 600 mg | 1 day | 10 |
| A low-fat spread with added plant sterols and fish omega-3 fatty acids lowers serum triglyceride and LDL-cholesterol concentrations in individuals with modest hypercholesterolaemia and hypertriglyceridaemia 2019 · Intervention group · Men and women aged 18–75 with fasting triglycerides of 1.40–5.60 mmol/L and LDL-C of 3.4–4.9 mmol/L | 2 g | 4 weeks | 130 |
| Changes in serum concentrations of noncholesterol sterols and lipoproteins in healthy subjects do not depend on the ratio of plant sterols to stanols in the diet 2003 · high sterol margarine · Healthy men and women | 1.5 g | 3 weeks | 44 |
| Changes in serum concentrations of noncholesterol sterols and lipoproteins in healthy subjects do not depend on the ratio of plant sterols to stanols in the diet 2003 · low sterol margarine · Healthy men and women | 1 g | 3 weeks | 44 |
| Effects of diets enriched with two different plant stanol ester mixtures on plasma ubiquinol-10 and fat-soluble antioxidant concentrations 2001 · vegetable oil-based stanols · Nonhypercholesterolemic adults; age and sex not specified | 3.8 g | 8 weeks | 36 |
| Effects of diets enriched with two different plant stanol ester mixtures on plasma ubiquinol-10 and fat-soluble antioxidant concentrations 2001 · wood-based stanols · Nonhypercholesterolemic adults; age and sex not specified | 4 g | 8 weeks | 34 |
| Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes 2006 · combination of glucomannan and plant sterols · Adults aged 38–74 years, mildly hypercholesterolemic, with or without type II diabetes | 1.8 g | 3 weeks | 34 |
| Acute effects of plant stanol esters on postprandial metabolism and its relation with changes in serum lipids after chronic intake 2015 · plant stanol ester shake and margarine period · healthy adults; age and sex not specified | 7 g | 3 weeks | 18 |
| High molecular weight oat β-glucan enhances lipid-lowering effects of phytosterols. A randomised controlled trial 2020 · PS-OBG · Hypercholesterolaemic individuals; age and sex not stated | 2 g | 6 weeks | 18 |
| Consumption of an oil composed of medium chain triacyglycerols, phytosterols, and N-3 fatty acids improves cardiovascular risk profile in overweight women 2003 · functional oil (FctO) diet · Overweight women; age range not reported | 22 mg/kg | 27 days | 17 |
| Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial 2018 · combination of phytosterols and curcumin (PS-CC) · Hypercholesterolaemic individuals; age range and sex not reported | 2 g | 4 weeks | 17 |
| Phytosterols and inulin-enriched soymilk increases glucagon-like peptide-1 secretion in healthy men: double-blind randomized controlled trial, subgroup study 2018 · Intervention group · Men aged 20 years or older, nondiabetic, described as healthy; 14 participants | 2 g | 8 weeks | 14 |
| Effects of non-esterified stanols in a liquid emulsion on cholesterol absorption and synthesis in hypercholesterolemic men 2002 · phytostanol treatment · mildly hypercholesterolemic men | 3 g | 3 days | 12 |
| Sitostanol administered in lecithin micelles potently reduces cholesterol absorption in humans 1999 · Sitostanol in lecithin micelles, 700 mg · Six healthy adults; age and sex not reported | 700 mg | 1 day | — |
| Sitostanol administered in lecithin micelles potently reduces cholesterol absorption in humans 1999 · Sitostanol in lecithin micelles, 300 mg · Six healthy adults; age and sex not reported | 300 mg | 1 day | — |
| Unesterified plant sterols and stanols do not affect LDL electrophoretic characteristics in hypercholesterolemic subjects 2004 · 50:50 mixture of sterols and stanols (SSN) · Healthy hypercholesterolemic subjects; age and sex not specified | 1.8 g | — | — |
| Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects 2005 · PSteE-milk plus PSteE-spread · Adults with modest hypercholesterolemia (total cholesterol 5–7.5 mmol/L) | 6 g | 3 weeks | — |
| Phytostanol tablets reduce human LDL-cholesterol 2005 · slowly disintegrating stanol lecithin capsules · Human subjects; age, sex, and health status not specified | 1.01 g | 6 weeks | — |
| Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols 2006 · FO-PS · Moderately overweight, hyperlipidemic adults; age and sex not specified | 1.7 g | 4 weeks | — |
| Daily consumption of a dark chocolate containing flavanols and added sterol esters affects cardiovascular risk factors in a normotensive population with elevated cholesterol 2008 · chocolate bar with plant sterols · Adults with elevated serum cholesterol and blood pressure ≤159/99 mm Hg; ages not reported | 2.2 g | 4 weeks | — |
| The lipid-lowering effects of phytosterols and (n-3) polyunsaturated fatty acids are synergistic and complementary in hyperlipidemic men and women 2008 · Combination of phytosterols and (n-3) LCPUFA · Men and women with hyperlipidemia; age range not reported | 2 g | 3 weeks | — |
| Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals 2009 · n-3 PUFA capsules with plant sterols · Hyperlipidemic participants; age and sex not specified | 2 g | 3 weeks | — |
| Independent and interactive effects of plant sterols and fish oil n-3 long-chain polyunsaturated fatty acids on the plasma lipid profile of mildly hyperlipidaemic Indian adults 2009 · Plant sterol-enriched yoghurt drink and fish oil capsules · Adults aged 35–55 years with mild hypercholesterolaemia | 2 g | 4 weeks | — |
| The effect of high-fiber rye bread enriched with nonesterified plant sterols on major serum lipids and apolipoproteins in normocholesterolemic individuals 2012 · Active group, first phase · Healthy normocholesterolemic individuals; age and sex not specified | 2 g | 2 weeks | — |
| The effect of high-fiber rye bread enriched with nonesterified plant sterols on major serum lipids and apolipoproteins in normocholesterolemic individuals 2012 · Active group, second phase · Healthy normocholesterolemic individuals; age and sex not specified | 4 g | 2 weeks | — |
| Combined effects of ezetimibe and phytosterols on cholesterol metabolism: a randomized, controlled feeding study in humans 2011 · Ezetimibe 10 mg/day + phytosterol supplement · Healthy adults aged 18–80 years with moderately elevated LDL cholesterol (100–189 mg/dL) | 2.5 g | 3 weeks | — |
| Effect of β-cryptoxanthin plus phytosterols on cardiovascular risk and bone turnover markers in post-menopausal women: a randomized crossover trial 2014 · β-Cx plus PS · Post-menopausal women; age and health conditions not specified | 1.5 g | 4 weeks | — |
| Low doses of eicosapentaenoic acid and docosahexaenoic acid from fish oil dose-dependently decrease serum triglyceride concentrations in the presence of plant sterols in hypercholesterolemic men and women 2014 · Intervention spread with 0.9 g/d EPA+DHA · Hypercholesterolemic men and women aged 25–74 years | 2.5 g | 4 weeks | — |
| Low doses of eicosapentaenoic acid and docosahexaenoic acid from fish oil dose-dependently decrease serum triglyceride concentrations in the presence of plant sterols in hypercholesterolemic men and women 2014 · Intervention spread with 1.3 g/d EPA+DHA · Hypercholesterolemic men and women aged 25–74 years | 2.5 g | 4 weeks | — |
| Low doses of eicosapentaenoic acid and docosahexaenoic acid from fish oil dose-dependently decrease serum triglyceride concentrations in the presence of plant sterols in hypercholesterolemic men and women 2014 · Intervention spread with 1.8 g/d EPA+DHA · Hypercholesterolemic men and women aged 25–74 years | 2.5 g | 4 weeks | — |
| The effect of plant sterols and different low doses of omega-3 fatty acids from fish oil on lipoprotein subclasses 2015 · PS (2.5 g/day) and EPA+DHA (0.9 g/day) spread · Hypercholesterolemic subjects; age and sex not specified | 2.5 g | 4 weeks | — |
| The effect of plant sterols and different low doses of omega-3 fatty acids from fish oil on lipoprotein subclasses 2015 · PS (2.5 g/day) and EPA+DHA (1.3 g/day) spread · Hypercholesterolemic subjects; age and sex not specified | 2.5 g | 4 weeks | — |
| The effect of plant sterols and different low doses of omega-3 fatty acids from fish oil on lipoprotein subclasses 2015 · PS (2.5 g/day) and EPA+DHA (1.8 g/day) spread · Hypercholesterolemic subjects; age and sex not specified | 2.5 g | 4 weeks | — |
| Combined effect of n-3 fatty acids and phytosterol esters on alleviating hepatic steatosis in non-alcoholic fatty liver disease subjects: a double-blind placebo-controlled clinical trial 2020 · PS + FO combination group · People with non-alcoholic fatty liver disease (NAFLD); age and sex not reported | 3.3 g | — | — |
| A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial 2019 · PS plus omega-3 fatty acids group · Adults aged 51–65 with impaired glucose regulation | 1.7 g | 12 weeks | 41 |
| The effect of meat products enriched with plant sterols and minerals on serum lipids and blood pressure 2004 · MP1 · Volunteers with mildly to moderately elevated serum cholesterol | 1.2 g | 3 weeks | — |
| The effect of meat products enriched with plant sterols and minerals on serum lipids and blood pressure 2004 · MP2 · Volunteers with mildly to moderately elevated serum cholesterol | 2.1 g | 3 weeks | — |
| Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals 2009 · Plant sterols without n-3 PUFA capsules · Hyperlipidemic participants; age and sex not specified | 2 g | 3 weeks | — |